Naz Rahman
Stock Analyst at Maxim Group
(0.19)
# 4,126
Out of 4,761 analysts
38
Total ratings
13.79%
Success rate
-44.44%
Average return
Main Sectors:
Stocks Rated by Naz Rahman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VKTX Viking Therapeutics | Maintains: Buy | $120 → $70 | $34.07 | +105.46% | 5 | Feb 7, 2025 | |
| NRSN NeuroSense Therapeutics | Downgrades: Hold | n/a | $1.09 | - | 2 | Dec 16, 2024 | |
| CING Cingulate | Upgrades: Buy | n/a | $4.27 | - | 4 | Nov 20, 2024 | |
| PALI Palisade Bio | Maintains: Buy | $23 → $8 | $0.94 | +748.18% | 7 | Nov 13, 2024 | |
| SLXN Silexion Therapeutics | Initiates: Buy | $9 | $0.84 | +965.21% | 1 | Nov 1, 2024 | |
| PRFX PainReform | Downgrades: Hold | n/a | $3.16 | - | 2 | Oct 24, 2024 | |
| VRPX Virpax Pharmaceuticals | Downgrades: Hold | n/a | $0.26 | - | 4 | Oct 9, 2024 | |
| ASRT Assertio Holdings | Initiates: Buy | $3 | $0.81 | +269.09% | 1 | Jul 26, 2024 | |
| QNRX Quoin Pharmaceuticals | Maintains: Buy | $15 → $4 | $0.32 | +1,152.74% | 2 | Mar 15, 2024 | |
| VRTX Vertex Pharmaceuticals | Downgrades: Hold | n/a | $484.24 | - | 1 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $0.13 | +3,100.00% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.53 | - | 3 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.35 | +270.37% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $20 | $3.25 | +515.38% | 2 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.25 | - | 1 | May 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $3.32 | +80.72% | 1 | Feb 25, 2022 |
Viking Therapeutics
Feb 7, 2025
Maintains: Buy
Price Target: $120 → $70
Current: $34.07
Upside: +105.46%
NeuroSense Therapeutics
Dec 16, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.09
Upside: -
Cingulate
Nov 20, 2024
Upgrades: Buy
Price Target: n/a
Current: $4.27
Upside: -
Palisade Bio
Nov 13, 2024
Maintains: Buy
Price Target: $23 → $8
Current: $0.94
Upside: +748.18%
Silexion Therapeutics
Nov 1, 2024
Initiates: Buy
Price Target: $9
Current: $0.84
Upside: +965.21%
PainReform
Oct 24, 2024
Downgrades: Hold
Price Target: n/a
Current: $3.16
Upside: -
Virpax Pharmaceuticals
Oct 9, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.26
Upside: -
Assertio Holdings
Jul 26, 2024
Initiates: Buy
Price Target: $3
Current: $0.81
Upside: +269.09%
Quoin Pharmaceuticals
Mar 15, 2024
Maintains: Buy
Price Target: $15 → $4
Current: $0.32
Upside: +1,152.74%
Vertex Pharmaceuticals
Jan 31, 2024
Downgrades: Hold
Price Target: n/a
Current: $484.24
Upside: -
Dec 8, 2023
Initiates: Buy
Price Target: $4
Current: $0.13
Upside: +3,100.00%
Nov 17, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.53
Upside: -
Aug 9, 2023
Initiates: Buy
Price Target: $5
Current: $1.35
Upside: +270.37%
May 11, 2023
Maintains: Buy
Price Target: $13 → $20
Current: $3.25
Upside: +515.38%
May 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.25
Upside: -
Feb 25, 2022
Initiates: Buy
Price Target: $6
Current: $3.32
Upside: +80.72%